Source: Thailand Medical News Dec 20, 2019 3 years ago
New research show that in laboratory experiments, a metabolic inhibitor was able to kill a variety of human cancer cells of the skin, breast, lung, cervix and soft tissues through a non-apoptotic route called catastrophic macropinocytosis.
In animal model xenograft studies, the inhibitor acted synergistically with a common chemotherapy drug, cyclophosphamide, to reduce tumor&nb...